BIOMARIN PHARMACEUTICAL INC Convertible Debt, Current
BIOMARIN PHARMACEUTICAL INC (BMRN) had Convertible Debt, Current of $0 as of 2024-12-31, per its 10-K filed 2025-02-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2025-02-24
- 2024-12-31: Convertible Debt, Current $0.00.
- 2024-09-30: Convertible Debt, Current $0.00.
- 2024-06-30: Convertible Debt, Current $494.84M.
- 2024-03-31: Convertible Debt, Current $494.36M.
| Period end | Convertible Debt, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-24 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-31 |
| 2024-06-30 | $494.84M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $494.36M 10-Q · filed 2024-04-26 |
| 2023-12-31 | $493.88M 10-K · filed 2025-02-24 |
| 2023-09-30 | $493.40M 10-Q · filed 2023-11-02 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-26 |
| 2020-12-31 | $0.00 10-K · filed 2021-02-26 |
| 2020-09-30 | $374.29M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $370.10M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $365.96M 10-Q · filed 2020-05-01 |
| 2019-12-31 | $361.88M 10-K · filed 2021-02-26 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2018-09-30 | $374.23M 10-Q · filed 2018-10-26 |
| 2018-06-30 | $369.75M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $365.33M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $360.95M 10-K · filed 2019-02-28 |
| 2017-09-30 | $0.00 10-Q · filed 2017-10-31 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-02 |
| 2017-03-31 | $22.50M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $22.48M 10-K · filed 2018-02-26 |
| 2016-09-30 | $22.46M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $24.42M 10-Q · filed 2016-08-08 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-27 |
| 2013-12-31 | $0.00 10-K · filed 2014-02-26 |
| 2013-09-30 | $0.00 10-Q · filed 2013-10-28 |
| 2013-06-30 | $0.00 10-Q · filed 2013-07-29 |
| 2013-03-31 | $0.00 10-Q · filed 2013-04-29 |
| 2012-12-31 | $23.36M 10-K · filed 2014-02-26 |
| 2012-09-30 | $23.44M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $23.44M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $23.45M 10-Q · filed 2012-04-30 |
| 2011-12-31 | $0.00 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |